Solara Pharma Sets April 2 Deadline for Final ₹112.50 Rights Share Payment

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Solara Pharma Sets April 2 Deadline for Final ₹112.50 Rights Share Payment
Overview

Solara Active Pharma Sciences has approved its second and final call of ₹112.50 per equity share for partly-paid rights shares. The record date is April 2, 2026. This final payment is crucial for the company's capital structure. Shareholders must pay by the deadline to avoid forfeiting their shares.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Solara Pharma Finalizes Rights Share Payments

Solara Active Pharma Sciences announced that its Rights Issue Committee has approved the second and final call for its partly-paid rights shares, demanding ₹112.50 per equity share. The company has set April 2, 2026, as the record date for this final capital collection, a move essential for finalizing the company's financial structure.

Final Call Details

The Rights Issue Committee convened on March 24, 2026, to authorize this demand. The ₹112.50 payment per share comprises ₹3.00 of face value and ₹109.50 as premium. The record date of April 2, 2026, will identify shareholders eligible to receive the official call notice for this final installment.

Financial Imperative

Successfully collecting these funds is crucial for Solara. It marks the final step in consolidating capital from its previous rights issue, thereby strengthening the company's financial foundation and supporting its ongoing operational and growth initiatives.

Background of the Rights Issue

This current call relates to shares issued during Solara Active Pharma Sciences' significant rights issue in May-June 2024. That offering aimed to raise approximately ₹449.95 crore at ₹375 per share, with the proceeds intended for growth and debt reduction.

Shareholder Obligation and Risk

Holders of these partly-paid rights shares must ensure the final ₹112.50 payment is made by the deadline communicated in the upcoming call notice. Failure to remit the payment by this due date will lead to the forfeiture of the shares.

API Sector Peers

Solara operates in the competitive API manufacturing sector. Its industry peers include companies such as Neuland Laboratories, Divi's Laboratories, Lupin, and Aarti Drugs, all serving global pharmaceutical markets.

Key Financial Metric

For the financial year ending March 31, 2025, Solara reported revenues of ₹1,290 crore.

Next Steps for Investors

Investors should monitor the dispatch of the official call notice, which will specify the exact payment deadline. The company's success in collecting this final call amount will serve as a key indicator of its capital management effectiveness and shareholder commitment.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.